Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease

Clinical trial NCT05492448 · TERMINATED

Trial details

NCT number: NCT05492448
Sponsor: Glac Biotech Co., Ltd
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes Chronic Obstructive Pulmonary Disease

Start date: 2022-09-19
Primary completion: 2025-08-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.